Currently, several antibiotics are active against methicillin-resistant Staphylococcus aureus (MRSA) and can be used for the treatment of pneumonia. They show great variability in terms of antibiotic class, indication, pharmacodynamic/pharmacokinetic properties, type of available formulations, spectrum of activity against bacteria other than MRSA, and toxicity profile.
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia
Bassetti, Matteo;Labate, Laura;Melchio, Monica;Robba, Chiara;Battaglini, Denise;Ball, Lorenzo;Pelosi, Paolo;Giacobbe, Daniele Roberto
2022-01-01
Abstract
Currently, several antibiotics are active against methicillin-resistant Staphylococcus aureus (MRSA) and can be used for the treatment of pneumonia. They show great variability in terms of antibiotic class, indication, pharmacodynamic/pharmacokinetic properties, type of available formulations, spectrum of activity against bacteria other than MRSA, and toxicity profile.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
